Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miR-148b Functions as a Tumor Suppressor in Pancreatic Cancer by Targeting AMPKα1
Gang Zhao, Jungang Zhang, Yang Liu, et al.
Molecular Cancer Therapeutics (2012) Vol. 12, Iss. 1, pp. 83-93
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

The AMP-activated protein kinase (AMPK) and cancer: Many faces of a metabolic regulator
Brandon Faubert, Emma E. Vincent, Maya C. Poffenberger, et al.
Cancer Letters (2014) Vol. 356, Iss. 2, pp. 165-170
Closed Access | Times Cited: 332
MicroRNAs in apoptosis, autophagy and necroptosis
Zhenyi Su, Zuozhang Yang, Yongqing Xu, et al.
Oncotarget (2015) Vol. 6, Iss. 11, pp. 8474-8490
Open Access | Times Cited: 330
H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/β-catenin in ox-LDL -stimulated vascular smooth muscle cells
Lei Zhang, Hailing Cheng, Yuxia Yue, et al.
Journal of Biomedical Science (2018) Vol. 25, Iss. 1
Open Access | Times Cited: 178
MicroRNA in pancreatic cancer
Keiichi Yonemori, Hiroshi Kurahara, Kosei Maemura, et al.
Journal of Human Genetics (2016) Vol. 62, Iss. 1, pp. 33-40
Closed Access | Times Cited: 139
MiR-130b Is a Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer through Targeting STAT3
Gang Zhao, Jungang Zhang, Yongyong Shi, et al.
PLoS ONE (2013) Vol. 8, Iss. 9, pp. e73803-e73803
Open Access | Times Cited: 125
Increases in miR-124-3p in Microglial Exosomes Confer Neuroprotective Effects by Targeting FIP200-Mediated Neuronal Autophagy Following Traumatic Brain Injury
Dai Li, Shan Huang, Zhenyu Yin, et al.
Neurochemical Research (2019) Vol. 44, Iss. 8, pp. 1903-1923
Closed Access | Times Cited: 111
The role of the miR‐148/‐152 family in physiology and disease
Michael Friedrich, Katharina Pracht, Mir‐Farzin Mashreghi, et al.
European Journal of Immunology (2017) Vol. 47, Iss. 12, pp. 2026-2038
Open Access | Times Cited: 108
MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway
Jungang Zhang, Yongyong Shi, Defei Hong, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 102
microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis
Adam E. Frampton, Jonathan Krell, Nigel B. Jamieson, et al.
European Journal of Cancer (2015) Vol. 51, Iss. 11, pp. 1389-1404
Closed Access | Times Cited: 101
Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway
Xiang Li, Shi-Jiang Deng, Shuai Zhu, et al.
Oncotarget (2016) Vol. 7, Iss. 5, pp. 6000-6014
Open Access | Times Cited: 99
Near‐Infrared Induced miR‐34a Delivery from Nanoparticles in Esophageal Cancer Treatment
Nick A. Alden, Tyus J. Yeingst, Hanna M. Pfeiffer, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 10
Open Access | Times Cited: 9
Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects
Daniel Neureiter
World Journal of Gastroenterology (2014) Vol. 20, Iss. 24, pp. 7830-7830
Open Access | Times Cited: 92
MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT)
Xiangming Ding
Chinese Journal of Cancer (2013) Vol. 33, Iss. 3, pp. 140-147
Open Access | Times Cited: 88
Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application
Valentin Taucher, Harald Mangge, Johannes Haybaeck
Cellular Oncology (2016) Vol. 39, Iss. 4, pp. 295-318
Closed Access | Times Cited: 83
MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines
Masoumeh Azizi, Ladan Teimoori‐Toolabi, Mohsen Karimi Arzanani, et al.
Cancer Biology & Therapy (2014) Vol. 15, Iss. 4, pp. 419-427
Open Access | Times Cited: 82
TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer
Davide Melisi, Rocio García‐Carbonero, Teresa Macarulla, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 83, Iss. 5, pp. 975-991
Closed Access | Times Cited: 75
miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer
Francesca Orso, Lorena Quirico, Federico Virga, et al.
Cancer Research (2016) Vol. 76, Iss. 17, pp. 5151-5162
Open Access | Times Cited: 68
New developments in AMPK and mTORC1 cross-talk
William J. Smiles, Ashley J. Ovens, Bruce E. Kemp, et al.
Essays in Biochemistry (2024) Vol. 68, Iss. 3, pp. 321-336
Closed Access | Times Cited: 6
MicroRNA-217 functions as a prognosis predictor and inhibits colorectal cancer cell proliferation and invasion via an AEG-1 dependent mechanism
Bo Wang, Zhanlong Shen, Kewei Jiang, et al.
BMC Cancer (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 64
MiR-548an, Transcriptionally Downregulated by HIF1α/HDAC1, Suppresses Tumorigenesis of Pancreatic Cancer by Targeting Vimentin Expression
Shuai Zhu, Chi He, Shi-Jiang Deng, et al.
Molecular Cancer Therapeutics (2016) Vol. 15, Iss. 9, pp. 2209-2219
Open Access | Times Cited: 59
Noncoding RNAs and pancreatic cancer
Juanfei Peng
World Journal of Gastroenterology (2016) Vol. 22, Iss. 2, pp. 801-801
Open Access | Times Cited: 58
miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression
Chengguang Sui, Fandong Meng, Yan Li, et al.
Journal of Translational Medicine (2015) Vol. 13, Iss. 1
Open Access | Times Cited: 57
MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine
Bethany Smith, Priyanka Agarwal, Neil A. Bhowmick
Endocrine Related Cancer (2017) Vol. 24, Iss. 5, pp. R157-R172
Open Access | Times Cited: 56
miRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1
Qinying Liu, Yangmei Xu, Shenghong Wei, et al.
Bioscience Reports (2015) Vol. 35, Iss. 4
Open Access | Times Cited: 55
Arsenic responsive microRNAs in vivo and their potential involvement in arsenic-induced oxidative stress
Xuefeng Ren, Daniel P. Gaile, Zhihong Gong, et al.
Toxicology and Applied Pharmacology (2015) Vol. 283, Iss. 3, pp. 198-209
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top